Your session is about to expire
← Back to Search
Project Dulce for Type 2 Diabetes
N/A
Recruiting
Led By Ahmed Khattab, MD
Research Sponsored by Scripps Whittier Diabetes Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Able to speak, read, write, and comprehend in English and Arabic
Diagnosed with type 2 diabetes mellitus (T2DM)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Study Summary
This trial aims to improve diabetes care for Arab Americans by providing culturally relevant educational resources & support.
Who is the study for?
This trial is for Arab-Americans who can communicate in English and Arabic, have type 2 diabetes with a recent HbA1c of at least 8%, and are registered or willing to register at the community clinic. They must not have severe illnesses, certain past malignancies, liver issues, anemia, other types of diabetes, or be pregnant.Check my eligibility
What is being tested?
Project Dulce Arabic is being tested; it's a culturally tailored education program for managing type 2 diabetes that includes peer-led sessions in Arabic and a text messaging service over three months. The goal is to improve patients' knowledge about diabetes and their self-care habits.See study design
What are the potential side effects?
Since this intervention involves educational resources rather than medication, typical drug side effects aren't expected. However, participants may experience stress or anxiety from lifestyle changes or information overload.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can speak, read, write, and understand both English and Arabic.
Select...
I have been diagnosed with type 2 diabetes.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Hypoglycemic Agents
Hypoglycemic Agents
Change from Baseline Health Belief Model Scale at 3 months
+5 moreSecondary outcome measures
Change in Baseline Food Frequency Questionnaire at 3 months
Change in Baseline Food Frequency Questionnaire at 6 months
Change in Baseline Glycosylated Hemoglobin A1C (HbA1c) at 3 months
+5 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Project Dulce + Dulce DigitalExperimental Treatment1 Intervention
Participants will participate in a peer-led group diabetes self-management education and support program and receive ongoing support via text messages designed to improve knowledge, health beliefs, self-management behaviors and clinical outcomes.
Find a Location
Who is running the clinical trial?
Scripps Whittier Diabetes InstituteLead Sponsor
17 Previous Clinical Trials
5,339 Total Patients Enrolled
Ahmed Khattab, MDPrincipal InvestigatorScripps
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You weigh less than a certain amount for your height.I can speak, read, write, and understand both English and Arabic.Your blood sugar level has been consistently high in the past month.You identify as Arab.I have type 1 diabetes or had diabetes during pregnancy.I am too ill to visit the clinic often.Your creatinine level is higher than 3.5.Your liver function tests show that your ALT and AST levels are more than three times the normal limit.I have anemia.My primary language is not English or Arabic.I am not willing to carry a mobile phone.I haven't donated blood or plasma recently.You are currently participating in Project Dulce.I have been cancer-free for over 5 years, or I've only had skin cancer.I have been diagnosed with type 2 diabetes.You have had issues with using drugs or alcohol in the past year.
Research Study Groups:
This trial has the following groups:- Group 1: Project Dulce + Dulce Digital
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger